Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel
JAMA · 2024
DOI: 10.1001/jama.2024.2985 ↗Kurz gefasst
Leitlinie in der Zeitschrift JAMA, 2024. Verfasst von Paul E Sax und 3 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV Infections. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Rajesh T. Gandhi, MD; Roger Bedimo, MD; Jennifer F. Hoy, MBBS; Raphael J. Landovitz, MD; Davey M. Smith, MD; Ellen F. Eaton, MD; Clara Lehmann, MD; Sandra A. Springer, MD; Paul E. Sax, MD; Melanie A. Thompson, MD; Constance A. Benson, MD; Susan P. Buchbinder, MD; Carlos del Rio, MD; Joseph J. Eron Jr, MD; Huldrych F. Günthard, MD; Jean-Michel Molina, MD; Donna M. Jacobsen, BS; Michael S. Saag, MD
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
- AIDS Research Consortium of Atlanta, Atlanta, Georgia.
- School of Medicine, University of Alabama at Birmingham.
Zitieren
APA
Sax, P. E., Thompson, M. A., Saag, M. S., & IAS-USA Treatment Guidelines Panel (2024). Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel. JAMA. https://doi.org/10.1001/jama.2024.2985
Vancouver
Sax PE, Thompson MA, Saag MS, IAS-USA Treatment Guidelines Panel. Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel. JAMA. 2024. doi:10.1001/jama.2024.2985
BibTeX
@article{Sax2024,
author = {Sax, Paul E and Thompson, Melanie A and Saag, Michael S and IAS-USA Treatment Guidelines Panel, IAS-USA Treatment Guidelines Panel},
title = {Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.2985}
}
EUVIMED